Intracellular Delivery III Market Entry Barriers of Nanomedicines /
A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new “drugs” will need to be delivered in a cell-and organelle-specific manner. Although efforts have been m...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
| Series: | Fundamental Biomedical Technologies,
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
